U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07423000) titled 'A Phase 1 Study of PVT401 in Healthy Subjects' on Feb. 09.
Brief Summary: The goal of this clinical trial is to learn what happens to PVT401 when it enters the human body and how it affects the immune system. It will also provide information about the safety of PVT401 after a single dose and after multiple doses. The main questions it aims to answer are:
Will participants experience any side effects when taking PVT401? How long does it take PVT401 to leave the body after it is administered?
Healthy volunteers will participate in either the single ascending dose (SAD) or multiple ascending dose (MAD) phase.
In the SAD phase, parti...